877052-29-4Relevant articles and documents
COMPOUNDS AS RAS INHIBITORS AND USE THEREOF
-
Paragraph 0203, (2019/04/11)
A compound of Formula (Ia) or (Ib), or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.
Arylbiguanides in heterocyclization reactions
Kryl'skii,Shikhaliev,Shestakov,Liberman
, p. 303 - 310 (2007/10/03)
The reactions of arylbiguanides with acetyacetone derivatives were used to obtain N-(pyrimidin-2-yl)-N′-arylguanidines, and the reactions with acetoacetic ester derivatives (depending on the structure of the keto esters), N-aryl-N′-(4-oxo-3,4-dihydropyrim